Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · Real-Time Price · USD
0.360
-0.040 (-9.95%)
At close: Apr 28, 2026, 4:00 PM EDT
0.369
+0.009 (2.53%)
Pre-market: Apr 29, 2026, 6:06 AM EDT
Mangoceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 6 | 11 | 6 | 6 | - | - |
| Market Cap Growth | -37.52% | 83.71% | 6.40% | - | - | - |
| Enterprise Value | 5 | 11 | 6 | 5 | - | - |
| Last Close Price | 0.36 | 0.74 | 2.42 | 4.15 | - | - |
| PS Ratio | 13.40 | 24.97 | 10.07 | 7.96 | - | - |
| PB Ratio | 0.38 | 0.75 | 0.45 | 7.52 | - | - |
| P/TBV Ratio | 6.31 | 11.77 | - | 7.52 | - | - |
| EV/Sales Ratio | 10.81 | 24.16 | 10.38 | 6.47 | - | - |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | 0.17 | 0.57 | -2.35 |
| Net Debt / Equity Ratio | -0.08 | -0.08 | 0.01 | -0.79 | -0.54 | -1.00 |
| Net Debt / EBITDA Ratio | 0.07 | 0.07 | -0.02 | 0.08 | 0.17 | - |
| Net Debt / FCF Ratio | 0.20 | 0.20 | -0.03 | 0.09 | 0.24 | -0.24 |
| Asset Turnover | 0.03 | 0.03 | 0.08 | 0.71 | 0.02 | - |
| Quick Ratio | 1.67 | 1.67 | 0.04 | 3.50 | 2.62 | 0.57 |
| Current Ratio | 1.74 | 1.74 | 0.05 | 3.96 | 2.67 | 0.57 |
| Return on Equity (ROE) | -141.66% | -141.66% | -118.31% | -1326.69% | -669.02% | - |
| Return on Assets (ROA) | -69.91% | -69.91% | -62.72% | -494.04% | -242.68% | - |
| Return on Capital Employed (ROCE) | -115.80% | -115.80% | -59.10% | -966.80% | -268.20% | 419.10% |
| Earnings Yield | -357.10% | -181.27% | -140.45% | -158.13% | - | - |
| FCF Yield | -95.75% | -51.37% | -78.46% | -120.17% | - | - |
| Buyback Yield / Dilution | -408.93% | -408.93% | -84.23% | -49.22% | -34.98% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.